Evidence map›Paper›PMID 41709741›Full record

ArticleHaematologica2026

Ruxolitinib in treatment-naive or corticosteroid-refractory pediatric patients with chronic graft-

Franco Locatelli, Bulent Antmen, Hyoung Jin Kang, Katsuyoshi Koh, Yoshiyuki Takahashi, Alphan Kupesiz, Maria Gabriela A Dias Matos, Yogi Chopra, Sunil Bhat, Ho Joon Im and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Franco LocatelliDepartment of Pediatric Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Catholic University of the Sacred Heart, Rome. franco.locatelli@opbg.net.
Bulent AntmenDivision of Pediatric Hematology and Oncology and Stem Cell Transplantation, Department of Pediatrics, Acıbadem Adana Hospital, Adana, Türkiye.
Hyoung Jin KangDepartment of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul.
Katsuyoshi KohDepartment of Hematology/ Oncology, Saitama Children's Medical Center, Saitama.
Yoshiyuki TakahashiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya.
Alphan KupesizPaediatric Hematology Oncology, Akdeniz University School of Medicine, Antalya, Türkiye.
Maria Gabriela A Dias MatosGRAACC, São Paulo.
Yogi ChopraDivision of Hematology/Oncology, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario.
Sunil BhatMazumdar Shaw Medical Center, Narayana Health City, Bangalore.
Ho Joon ImDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul.
Tayfun GüngörDepartment of Hematology/Oncology/Immunology, Gene Therapy, and Stem Cell Transplantation, University Children's Hospital Zürich, Eleonore Foundation and Children's Research Center, Zurich.
Meng-Yao LuDepartment of Pediatrics, National Taiwan University Hospital, Taipei.
Tommaso StefanelliNovartis Pharma AG, Basel.
Severine PeyrardNovartis Pharma S.A.S, Paris.
Yvonne SmithNovartis Ireland Limited, Dublin.
Karen SinclairNovartis Pharma AG, Basel.
Cristina Diaz-de-HerediaDivision of Pediatric Hematology and Oncology and Stem Cell Transplantation, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41709741
PMCPMC13482220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.